Milioli Heloisa Helena
Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine, Hunter Medical Research Institute, New Lambton Heights NSW, Australia; School of Environmental & Life Sciences, The University of Newcastle, Callaghan NSW, Australia; Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine, Hunter Medical Research Institute, New Lambton Heights NSW, Australia; School of Environmental & Life Sciences, The University of Newcastle, Callaghan NSW, Australia.
Future Sci OA. 2015 Sep 11;1(4):FSO69. doi: 10.4155/fso.15.69. eCollection 2015 Nov.
The IMPAKT 2015 Breast Cancer Conference was designed for researchers and clinicians by the Breast International Group (BIG) and the European Society for Medical Oncology (ESMO). The event was held on 7-9 May in Brussels, Belgium, bringing together approximately 525 participants with a special interest in translational science and state-of-the-art applications in the clinical setting. Oncologists, pathologists and scientists collaborated to develop innovative ideas about breast cancer research and to enhance its relevance to patient care. This report highlights the most recent discussions in fundamental research and future clinical perspectives presented by professionals from around the world. It also covers the important issues regarding new technologies for biomarker discovery and the actual path to clinical utility.
IMPAKT 2015乳腺癌会议由国际乳腺癌研究协作组（BIG）和欧洲肿瘤内科学会（ESMO）为研究人员和临床医生举办。该活动于5月7日至9日在比利时布鲁塞尔举行，汇聚了约525名对转化科学及临床环境中的前沿应用有着特殊兴趣的参与者。肿瘤学家、病理学家和科学家共同合作，就乳腺癌研究提出创新理念，并提高其与患者护理的相关性。本报告重点介绍了来自世界各地的专业人士在基础研究方面的最新讨论以及未来的临床前景。它还涵盖了生物标志物发现新技术以及临床应用实际途径的重要问题。
